This compound is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). It is particularly significant in the development of drugs targeting central nervous system disorders, including antidepressants and antipsychotics. Its cyclopropyl group and chiral structure make it valuable for creating molecules with specific biological activity and selectivity. Additionally, it is employed in research settings for the study of enzyme inhibition and receptor binding, aiding in the discovery of novel therapeutic agents. Its hydrochloride form enhances solubility, making it suitable for formulation in drug delivery systems.